Adverse Events Following COVID-19 Vaccination

COVID-19 Vaccine adverse events is a challenging topic because they are so numerous and of broad variety.

Research shows that the treatment arm of Covid 19 vaccine trials had significantly more adverse events than the placebo arm.¹⁾ Several databases are tracking adverse events resulting from the widespread public roll out of these vaccines.

See also: CoVid-19 Vaccine Associated Myocarditis

See also: CoVid-19 Vaccine Associated Myopericarditis

Myopericarditis is characterized as inflammation of the pericardium, the membrane surrounding the hear, with involvement of the myocardium. Symptoms include chest pain, fever, and shortness of breath, and are similar to pericarditis. Involvement of the myocardium is diagnosed though testing for elevated troponin through cardiac imaging.

See also: CoVid-19 Vaccine Associated Pericarditis

See also: CoVid-19 Vaccine Takotsubo Cardiomyopathy

https://www.thecardiologyadvisor.com/home/topics/acs/acute-coronary-syndrome-acs-biomarkers-mrna-covid19-vaccine/

• Aug 18, 2021| Li et al Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model

From 2020-2021, a localized epidemic of sudden neurological diseases have appeared affecting patients from their 20s to their 80s in the Province of New Brunswick, Canada. “If a group of people wanted to breed conspiracy theorists, then our government has done a wonderful job at promoting it,” said Tim Beatty, son of one victim. “Are they just trying to create a narrative for the public that they hope we’ll absorb and walk away from? I just don’t understand it.”²⁾ It is unclear what the cause of the epidemic is, and the New Brunswick government appears to be trying to suppress a deeper investigation.

Numerous studies show significantly higher rates of adverse events amongst those who previously had COVID-19 infections.

• "Short-term severe symptoms that required medical attention were found in 6.8% among the post-infected individuals, while none were found in the infection naïve population."
• "Systemic side-effects were more common (1·6 times after the first dose of ChAdOx1 nCoV-19 and 2·9 times after the first dose of BNT162b2) among individuals with previous SARS-CoV-2 infection than among those without known past infection."
• "A prior COVID-19 infection was associated with an increased risk of any side effect.... It was also associated with an increased risk of severe side effects leading to hospital care."
• "Vaccine recipients with preexisting immunity had systemic side effects at higher frequencies than those without preexisting immunity"
• "The proportion of participants reporting at least one moderate-to-severe symptom was higher in the previous COVID-19 group"
• See also ³⁾, ⁴⁾, ⁵⁾, ⁶⁾

Some researchers worry that a small number of vaccine lots or batches are harming large numbers of people.

https://www.bitchute.com/video/4HlIyBmOEJeY/